During its regular 2021 session, the 67th Washington State Legislature passed two bills regarding the production or purchasing, distribution and access of pharmaceuticals. Senate Bill 5195 directs the Washington Health Care Authority (HCA) to establish a bulk purchasing and distribution program for “opioid overdose reversal medication” (2SSB 5195.SL). Senate Bill 5203 directs HCA to establish partnerships to produce, distribute or purchase generic prescription drugs and insulin (ESSB 5203.SL).
HCA is interested in gathering feedback from key stakeholders on how such programs could be developed and implemented. HCA created a survey where you can provide input regarding the barriers to and opportunities for new purchasing and distribution approaches for insulin and naloxone.
The survey should take no more than 10 minutes to complete and will be open through Nov. 5, 2021. Your time and insights are appreciated. (Health Care Authority)